BioSpace News Archive

CA Veterinary Medical Board announces telemedicine may only be used with existing patients and for preexisting conditions, according to PetHospice

Neogen Corporation announced that James Herbert has resigned as its chairman, and he has been succeeded by Jim Borel.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that its anti-PD-1 antibody tislelizumab has received approval from the China National Medical Products Administration

The document attached to this press release is a statement from Andre Watson, a scientist who is the founder, chairman and CEO of Ligandal, Inc.

– Closed enrollment for olinciguat Phase 2 STRONG SCD study for sickle cell disease; topline data readout expected Q3 2020 – – Closed enrollment for IW-6463 translational pharmacology clinical study ; topline data readout expected mid-year 2020 – – Company continues discussions to out-license praliciguat – CAMBRIDGE, Mass., April 10, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the development o

Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, April 30, 2020, the Company will release financial results for the fourth quarter of fiscal 2020. The Company will host a conference call to discuss the results on Thursday, April 30, 2020, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call. To listen to

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to begin a Phase 1/2a clinical trial of ARO-ENaC, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with cystic fibrosis (CF), which is a rare disease caused by genetic mutations that lead to progressive deterioration in lung function due to poor cleara

CHI Institute’s mission for the last 30 years, has been to provide the tools and research to enhance your human experience.

Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company, today announced the appointment of Dr. Yun-Fu Hu as Chief Medical Officer

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the appointment of Sir Harpal Kumar as President of GRAIL Europe. In this new role, Sir Harpal will be responsible for leading GRAIL’s entry and growth in Europe. “I am delighted to welcome Harpal to the GRAIL team. He is a passionate advocate for better outcomes in cancer, with a widely recognized ap